STAA staar.com: Company Value to Revenue

STAAR Surgical Company (STAA) maintains high operating margins and stable cash flow based on its technological leadership in lens manufacturing. The EV/Sales ratio reflects market expectations, with the indicator reaching 3301.52. A loyal team of R&D specialists drives innovation, although final demand is influenced by aesthetic medicine cycles, causing patients to postpone surgeries during recessionary periods.
STAA (STAAR Surgical Co): analytical breakdowns and indicator data

This indicator determines the market value of the business, accounting for net debt relative to generated revenue. The EV/Sales multiple trend helps identify hidden asset overvaluation when market expectations are inflated. The calculation excludes the influence of borrowing structures, focusing instead on the actual value of operating assets. For STAAR Surgical Company (STAA), such a valuation confirms the efficiency of owning lens production. Control over key technologies reduces vendor risks, stabilizing the company's fundamental value.